Example: Heart Attack

Clinical Trials on Abruptio Placentae

Total 149 results

NCT03782168

Recruiting

Plasma Concentration of Biological Markers in Placental Abruption

Conditions: Abruptio Placentae
NCT04449601

Completed

Normotensive and Hypertensive Placental Abruptions

Conditions: Abruptio Placentae; Affecting Fetus or Newborn
NCT01279369

Terminated

The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

Conditions: Pregnancy Related; Trauma; Abruptio Placentae
NCT00186069

Completed

Magnesium Sulfate vs Placebo for Placental Abruption

Conditions: Abruptio Placentae
NCT04168606

Completed

Study on Retroplacental Hematomas in Finistère

Conditions: Placental Abruption; Placenta Diseases
NCT01589744

Terminated

Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted

Conditions: No Placental Abruption; No Hemorrhage
NCT00986765

Completed

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia

Conditions: Preeclampsia
NCT01044082

Completed

Prevention of Post-partum Haemorrhage

Conditions: Postpartum Haemorrhage; Immediate Postpartum Hemorrhage
NCT00573118

Unknown status

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

Conditions: Pregnancy Complications; Preeclampsia; Placental Abruption; Intrauterine Fetal Growth Restriction; Intrauterine Fetal Death
NCT02480556

Completed

Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management

Conditions: Haemorrhage
NCT04356326

Not yet recruiting

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Conditions: Chronic Hypertension Complicating Pregnancy; Pre-Eclampsia; Intrauterine Growth Restriction; Aspirin; Perinatal Death; Placental Abruption
NCT02855047

Completed

The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations

Conditions: Antiphospholipid Syndrome
NCT04401839

Not yet recruiting

Amr Maneuver for Prevention of Postpartum Hemorrhage

Conditions: Post Partum Hemorrhage
NCT01501890

Withdrawn

Progesterone for First Trimester Vaginal Bleeding

Conditions: Threatened Abortion; Pre-Eclampsia; Abruptio Placentae; Fetal Growth Retardation; Premature Birth
NCT01068795

Completed

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Conditions: Fetal Demise; Fetal Growth Restriction; Preeclampsia; Abruptio Placentae; Thromboembolism
NCT01547390

Terminated

Early Prevention of Preeclampsia Study

Conditions: Preeclampsia
NCT01244347

Unknown status

Folic Acid Dosage and Malformations Reduction

Conditions: Congenital Malformations
NCT01355822

Completed

Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies

Conditions: High Risk Pregnancy
NCT03664999

Completed

Serum Immunologic Markers Levels in During the Delivery

Conditions: Immunologic Markers
NCT03455387

Recruiting

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

Conditions: Pre-Eclampsia; HELLP Syndrome; Fetal Death; Eclampsia; Placental Abruption; Fetal Growth Retardation, Antenatal
NCT00642980

Completed

Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis

Conditions: Pregnancy
NCT04518176

Recruiting

Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins

Conditions: Cesarean Section Complications
NCT04518163

Recruiting

Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

Conditions: Placenta Previa
NCT04518150

Recruiting

Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section

Conditions: Placenta Previa
NCT03591679

Completed

Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section

Conditions: Post Partum Hemorrhage